AzTrials
AzTrials

Exercise TrainingNCT03208751

Sport as Therapy: a 6-months Lifestyle-Intervention for Patients With Coronary Artery Disease and/or Diabetes

A study testing Exercise training in people with Exercise Training and Coronary Artery Disease, run by Technical University of Munich at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Regular exercise training has shown to improve exercise capacity in patients with cardiovascular disease. The feasibility and transferability of exercise training in a community based cardiovascular rehabilitation setting is currently less well investigated. Read more about this study

Who is it for?
Ages 18 to 85 years
What is being tested?
Exercise training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteGermany
Study dates
1 Apr 2011to 1 Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Coronary artery disease and/or diabetes mellitus
  • Heart failure

Who cannot join

  • all conditions which are not compatible with exercise training:
  • severe orthopedic disorders
  • severe psychiatric disease
  • severe valve insufficiency
  • presence of myocardial ischemia (decision made by cardiologist)

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Klinikum rechts der Isar/ Technische Universitaet Muenchen

    Munich, 81675

Other trials in Germany

About this study

Official title: A 6-months Lifestyle Intervention With Interval and Resistance Exercise in Patients With Coronary Artery Disease and Diabetes Mellitus in a Community Based Setting

Regular exercise training has shown to improve exercise capacity in patients with cardiovascular disease. The feasibility and transferability of exercise training in a community based cardiovascular rehabilitation setting is currently less well investigated. The objective of this study is to translate regular exercise training into a community based setting. A 6 months training intervention program with lifestyle counseling is performed, with both supervised training in rehabilitation centres as well as home based training. The aim of the project is to implement this program for a wider patient population and to improve exercise capacity, diastolic function as well as cardiometabolic parameters.

Read the detailed description

From 2011, patients insured at "Techniker" health insurance company with diagnosed coronary heart disease, heart failure and/or diabetes mellitus are being included in a 6-months training program. Training is performed 3 times weekly for 6 weeks, then twice weekly for another 6 weeks, while patients are asked to do home based training. The last phase of 12 weeks, supervised training is only once/week. Patients are asked to perform exercise training 3-5 times weekly. At the beginning as well as after 3 and 6 months, patients present for medical check-up with cardiorespiratory exercise testing from which training instructions are drawn. Training-intensity begins with moderate continuous training and switches to higher intensity interval training after 6 weeks. Resistance training starts after 6 weeks and is performed within the supervised training. All patients were offered an individual nutritional counseling.

Being tested
Exercise training
Medical subject headings
Coronary Artery Disease, Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise trainingBehavioural

    Exercise intervention was divided into 3 phases:

    Phase 1: 6 weeks of moderate continuous training (MCT) 20 to 40 minutes at intensity of 60% of VO2peak, 3 times/week Phase 2: 6 weeks of moderate intensity interval training (MIIT) 30-40 min, intensity 60 to 80% of VO2peak, twice weekly plus at least once weekly MCT home based training Phase 3 (after performing new exercise testing to adapt training intensities): 12 weeks of MIIT 40 min once/week, intensity 60-80/85% of VO2peak, plus at least twice weekly home based MCT. From phase 2, supervised sessions included resistance training of at least 3 muscle groups, 3x15 repetitions at moderate intensity (Borg 12-14).

    Nutritional counseling is offered up to 4 times in 6 months on an individual basis.

Study groups in NCT03208751
Study groupRoleWhat they receive
Exercise trainingOtherAll patients were included in the exercise training group
Receives: Behavioral: Exercise training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in VO2peak in ml/kg/min

    Exercise capacity measured by cardiorespiratory exercise testing from start to the end of 6 months training intervention

    Measured: 6 months

Secondary outcomes (11)
  1. Change in HbA1c for patients with diabetes

    Glycated hemoglobin >5,7 corresponds to glucose intolerance, > 6,5 is diagnosed diabetes mellitus

    Measured: 6 months

  2. Change in hsCRP

    high sensitivity C-reactive protein, as an inflammation marker and risk marker for further CAD events

    Measured: 6 months

  3. Change in E/e'

    E/e' is an echocardiographic marker for diastolic function, an E/e' < 8 is considered as normal

    Measured: 6 months

  4. Change in quality of life measured by SF-36

    The short form (SF-36) is a validated questionnaire for quality of life, the physical and psychical sum scale are measured

    Measured: 6 months

  5. Change in insulin IU

    Insulin dosage is measured in IE (international units)

    Measured: 6 months

  6. Change in HDL- and LDL- cholesterol as well as triglycerides

    all measured in mg/dl

    Measured: 6 months

  7. Change in Adiponectin

    Adiponectin is an adipokine which is released by fat tissue

    Measured: 6 months

  8. Change in Watts at anaerobic threshold VAT

    VAT= ventilatory anaerobic threshold, measured by cardiopulmonary exercise testing

    Measured: 6 months

  9. Change in Watts at anaerobic threshold RCP

    RCP= respiratory compensation point, measured by cardiopulmonary exercise testing

    Measured: 6 months

  10. Change in max. Watts

    On bicycle ergometry, Watts are measured

    Measured: 6 months

  11. Change in max. Watts/kg bodyweight

    max. Watts indexed b body weight

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2017
  2. Study start1 Apr 2011
  3. Primary completion1 Aug 2019 (estimated)
  4. Study completion1 Jan 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
A single-arm intervention with exercise training as secondary prevention strategy
Masking
None (open label)
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03208751
Sponsor's protocol ID
5132/11
Status last verified
Jul 2019
First submitted
26 May 2017
Last updated
19 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise training in people with Exercise Training and Coronary Artery Disease, run by Technical University of Munich at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in VO2peak in ml/kg/min (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in